Medical electronic devices are caught in an almost constant cycle of recall. From diagnostic systems to battery-powered monitoring equipment, safety notices land with regular frequency. It exposes manufacturers, hospitals, clinicians and patients to the rigours of regular recall.
While the overall objective of preventing faults and improving performance is the right one, the impact of recalls is considerable. When a device is in use on a ward or in a patient’s home, the issue shifts from design to response. Hospitals must trace affected units, isolate them and maintain care without disruption. At the same time, patient care can be at best, disrupted and, in extreme cases, put at risk. On top of all of this, manufacturers must deal with the administrative and regulatory burden of swapping one product for another – often in many languages.
A system under strain
It’s little wonder the current system is under strain. Recent reports confirmed that medical device recalls in the UK and EU have reached a ten year high. In the UK alone, the Medicines and Healthcare products Regulatory Agency (MHRA) commissioned benefit risk evaluations for nearly 310 medical device failed safety notices in 2024 and 2025, reflecting sustained pressure across the system.
Part of this trend are linked to the progress itself: Devices are smaller, smarter and more connected. AI-driven image analysis, remote monitoring platforms and portable diagnostics are now embedded in everyday care. At a system level, healthcare is now truly global. A unit designed in Germany may be assembled in Asia, shipped through multiple distributors, and ends up in a clinic in Korea or a home in Holland. Keeping track of where every device sits at any moment is a monumental task. When units need identifying, isolating or replacing, that complexity multiplies.
Failures occur because components degrade, batteries overheat and firmware behaves unpredictably in real world conditions. In healthcare, any uncertainty around safety is taken seriously. And rightly so – patient safety will always outweigh commercial hesitation. That culture of caution increases the likelihood that issues move quickly from observation to formal recall.
On top of all this, regulations continue to evolve. The EU Medical Device Regulation has raised the bar for post-market surveillance and documentation. Manufacturers must monitor performance continuously and act quickly when risk emerges. What may once have been handled quietly as a service action is now more likely to trigger a formal failed safety notice.
None of these pressures are temporary. That is why the way medical electronics recalls are handled must improve. If the environment is not becoming simpler, the response can’t remain static.
Rethinking how recalls are handled
There are clear ways the current system can improve, especially in medical electronics where traceability and documentation are critical:
Design for digital traceability:
Every device should be linked to batch data, firmware versions and component histories in a structured way. When an issue emerges, affected units must be identified within hours, not weeks.
QR codes and digital portals can support faster identification in clinical settings.
Move beyond paper notices:
Paper letters and static website notices are too slow. Hospitals and clinicians expect live updates.
Digital recall journeys allow users to confirm serial numbers, upload images and track resolution in real time.
Use AI to manage scale:
Recalls generate call volumes, emails and documentation demands. AI driven triage can handle routine queries, guide users through next steps and reduce manual workload. Where used effectively, organisations have cut recall costs by up to 40% whilst improving response speed.
Turn unknown users into known contacts:
Not all devices are registered. In some cases, the end user may not be the original purchaser.
Connected data and digital engagement tools can help identify and reach users who would otherwise remain invisible.
Build a defencible audit trail from day one:
Regulators expect evidence. Every interaction, confirmation and corrective action should be logged automatically.
A complete digital record reduces legal exposure and supports transparent reporting.
Treat recalls as a permanent capability:
Recalls are not rare events. They are a recurring feature of complex electronics manufacturing. Investing in a recall ready infrastructure in advance is far more cost effective.
From reactive to recall ready
The medical electronics sector can’t eliminate recall risk entirely. However, in an area where recalls are part of daily life, the sector can be better equipped. It can be recall ready. It can put the preparatory measures in place so that when – and not, if – a recall happens, the response is structured, fast and data rich. One that minimises disruption in clinical settings and provides clear evidence to regulators.
Medical electronic devices are built on precision and control. However, many recall processes are an analogue process in a digital age, making them not fit for purpose.
As recall volumes rise, the real measure of a manufacturer will not only be how well it designs devices, but how well it responds when something goes wrong.
By Pete Gillett, CEO, Marketpoint Recall
